The Dutch government is providing €1.9 million ($2.25 million) in research funding for a study aimed at finding an optimal balance between THC and CBD dosages in medical cannabis for the treatment of neuropathic pain.
The grant has been awarded to a joint project of the Centre for Human Drug Research (CHDR), a Dutch clinical drug research institute, and the Leiden University Medical Center (LUMC).
Take this pill
“We are going to isolate the THC and CBD . . . and administer them in tablet form in different proportions. We will then look at the influence of CBD on the effects of THC, and investigate which THC-CBD combination is best for the treatment of neuropathic pain”, said Neurologist Geert Jan Groeneveld of CHDR. Groeneveld is CSO, CMO at CHDR, and professor of Clinical Neuropharmacology at the LUMC. He is conducting the research with and Albert Dahan, professor of Anesthesiology at the LUMC.
Dutch company Bedrocan’s raw materials will be used for the production of the research material; Echo Pharmaceuticals, Leiden, Netherlands, will produce the tablets for the research, Bedrocan said in a press release.